Asthma - management

Short-acting ß2-agonists and greenhouse gas emissions in Europe and Canada
Christer Janson, Ekaterina Maslova, Alexander Wilkinson, Erika Penz, Alberto Papi, Nigel Budgen, Claus F. Vogelmeier, Maciej Kupczyk, John Bell, Andrew Menzies-Gow

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3549; DOI: 10.1183/13993003.congress-2021.PA3549
Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A
Charles Pilette, Giorgio Walter Canonica, Rekha Chaudhuri, F. Eun-Hyung Lee, Jason Kihyuk Lee, Carlos Almonacid Sanchez, Rafael Alfonso-Cristancho, Rupert Jakes, Aoife Maxwell, Robert Price, Peter Howarth

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3539; DOI: 10.1183/13993003.congress-2021.PA3539
Evaluation of Asthma control and oral corticosteroids in Severe Asthma
Claudio Micheletto, Maria Beatrice Bilò, Leonardo Antonicelli, Fausto De Michele, Antonino Musarra, Adriano Vagni

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3529; DOI: 10.1183/13993003.congress-2021.PA3529
Mometasone/indacaterol/glycopyrronium (MF/IND/GLY) improves lung function and reduces exacerbations in patients with asthma, independent of baseline airflow limitation: Results from IRIDIUM study
Konstantinos Kostikas, Huib A. M. Kerstjens, Jorge F. Maspero, Kenneth R. Chapman, Richard N. Van Zyl-Smit, Motoi Hosoe, Ana-Maria Tanase, Abhijit Pethe, Ioannis Kottakis, Peter D'Andrea

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3392; DOI: 10.1183/13993003.congress-2021.PA3392
Mometasone/indacaterol (MF/IND) and mometasone/indacaterol/glycopyrronium (MF/IND/GLY) versus fluticasone/salmeterol (FLU/SAL) and FLU/SAL+tiotropium (TIO) in patients with inadequately controlled asthma: data from the PLATINUM program
Richard Van Zyl-Smit, Kenneth Chapman, Huib Kerstjens, Christian Gessner, Hironori Sagara, Ana-Maria Tanase, Motoi Hosoe, Xu Shu, Abhijit Pethe, David Lawrence, Hanns-Christian Tillmann, Karen Mezzi, Peter D’Andrea

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3385; DOI: 10.1183/13993003.congress-2021.PA3385
Real-world treatment patterns of newly diagnosed patients with asthma and/or COPD
Aniek Markus, Peter Rijnbeek, Jan Kors, Guy Brusselle, Edward Burn, Daniel Prieto-Alhambra, Katia Verhamme

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3520; DOI: 10.1183/13993003.congress-2021.PA3520
Exploring the psychological impact of the COVID-19 pandemic on adults with asthma: A quantitative study
Kirstie McClatchey, Tracy Jackson, Emma Kinley, Amy Chan, Noelle Morgan, Jessica Rees, Hilary Pinnock

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3562; DOI: 10.1183/13993003.congress-2021.PA3562
Efficacy of different dosing regimens of azithromycin in a real-world severe asthma cohort
Ayesha Kumar, Seher Zaidi, Nicola Fay, Thomas Fitzmaurice, Abigail Watkin, Hannah Joplin, Hassan Burhan

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3526; DOI: 10.1183/13993003.congress-2021.PA3526
Community pharmacist counseling improves adherence and asthma control: a nationwide observational study
Barbara Putman, Anna Vanoverschelde, Els Mehuys, Louise Coucke, Lies Lahousse

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3394; DOI: 10.1183/13993003.congress-2021.PA3394
SABA use increase weeks before asthma exacerbations recorded via a digital inhaler
Mark Levy, Guilherme Safioti, Michael Reich, Randall Brown, Michael Depietro

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3397; DOI: 10.1183/13993003.congress-2021.PA3397

Main menu

User menu

Search

Asthma - management

Pages

Contact us